{"name":"Institut Català d'Oncologia","slug":"institut-catal-d-oncologia","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5pZXpPVm1HZnhad2xHS00zVGdtUjRHcnFNZ2hlLVlQYzlMay1BSEZVaWg0SW9GT0NWU0Ywd1g2QnU0ZWRpZGhQTHBvVVRLcndIdkhoVUtHYW1wdk1VaUxj?oc=5","date":"2026-01-06","type":"trial","source":"nature.com","summary":"Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study - nature.com","headline":"Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOa09VMkhieDB3VVJMTUdzYmZSS3FpTUt2R0g5aHhSVEsyWFJfX3FiRUV1TXpMODUxbmtUa2pIVjFpVm1KYnF4MEplTUkwNVBWbG5DUXVWRmlBMGJkbTlEaVBUdFR5Slk5bEREYjFNdG9QbWRYQXZSZ2J4UTQ3WnFuaWFYRkpWYUdCME5WTEFFTDM0YWNzUjhzS1ZZTy0zaEhYQUUzZS1OVlZ5NzRXZXpvX3hDczdkTEU?oc=5","date":"2024-04-09","type":"trial","source":"Fierce Pharma","summary":"AACR: Detailed data spark glimmer of hope for Merck's Keytruda-Lynparza combo in lung cancer - Fierce Pharma","headline":"AACR: Detailed data spark glimmer of hope for Merck's Keytruda-Lynparza combo in lung cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBzVjh4WTR5Z1RFUTNCcEJ0RkxmNjJtaGt4NXdGOWtPOFAwZ0pNMHJsaktTcXlHRXoxTjc5OGNMMWZreDl2MlkwakxaSGc2ZTFLdS1YLXF3R2p2MXQ5bllN?oc=5","date":"2023-05-23","type":"pipeline","source":"nature.com","summary":"Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung origin - nature.com","headline":"Durvalumab plus tremelimumab for the treatment of advanced neuroendocrine neoplasms of gastroenteropancreatic and lung o","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxQb3Atck82TTM5ZU5mTGVVNDA1Y0d2Z2h0OWk2cVJyaWZRYTNSMkZqVi1ibEphZ0Z3bnlZRTBQUzF0cjYwMGRpQUdKMmh2NkIxRFBrV3RJMm84M2g5VnlxaG84RjZDNjBic1B4NGhRSUEyYWdVTHlXaG8yUlNNTnhIOVNUczBnZnp4ejNOOHF5SUhuNWtDN0w3ck1CSkZ0WVVkUGJqbEVROThieEZFc0dWc0l6anYxY0JNcUdIU090Q3JvZnp2U2tscDVudFJTTzdfc0VvYnRNcmdMaVctdkZlcy02d19Da0kyb3Z1bDloelR6OU9n?oc=5","date":"2021-11-12","type":"pipeline","source":"European Medical Journal","summary":"Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients? - European Medical Journal","headline":"Immunotherapies for Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Which Antibodies for Which Patients?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxOUEE2eEFRazI0N1NHRktZQWlrcElfb01LMGhUUmVLaWtPMDZudzlMdGpPZTdlVTZCV1dOY3d5NjRaSkxEaVNNR0w2alF6dFZuTjlrYy1YdmFuc2JINURCdWdUTmdQRThDcTBXRGF4aktOUkRRUC1RR3lzOGl0RGk0aXJ4cGdhU18tQjc5WUkzT0xhb29hb0Rac1JhVzhCRWlfcWZJVTln0gGrAUFVX3lxTFByU1FPeUdhZ0RnLTJkQnB4S2pVelRwOWxtb1k2RzVKYkU2UWJkOFc4NmxLRVIzYlNTd1ctdGZjYUM4LTBHb2Z6V0tEOHUwOE9OUjY2WUdhZEJzd0VWcVd6d0tCM1NJSHZ1U1VIOGg5bUFNZkdZWjk3QTJpSkxVb0xYaE1IRlJHcDNTOFJMY09XM0syZy1PYXJJaDFibGNzSFBCazFrbWVOcUpoRQ?oc=5","date":"2015-10-17","type":"pipeline","source":"Inquirer.net","summary":"Takeda launches new treatment for Hodgkin’s lymphoma in Philippines - Inquirer.net","headline":"Takeda launches new treatment for Hodgkin’s lymphoma in Philippines","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}